Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Late-Breaking Clinical Trials Coronary

LATE-BREAKING CLINICAL TRIALS | CORONARY

Saturday, March 8, 2025
2:00 PM – 3:15 PM ET

    Late Breaker Moderator(s)

  • Dean J. Kereiakes, MD, FACC, MSCAI

    Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
    The Christ Hospital Health Network
    Cincinnati, Ohio, United States

    Disclosure(s): Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Elixir Medical Corporation: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); JC Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Orchestra Biomed: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Sino Medical Sciences Technology, Inc.: Consultant (Ongoing)

  • Gregg W. Stone, MD, FACC, MSCAI

    Physician
    Mount Sinai
    New York, New York, United States

    Disclosure(s): Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)

    • Panelist(s)

  • Bernardo Cortese, MD, FESC, FSCAI

    Director of Coronary Program
    University Hospitals
    Cleveland, Ohio, United States

    Disclosure information not submitted.

  • David G. Rizik, MD, MSCAI, FACC

    Chief Scientific Officer, Chief of Complex Interventional Cardiology, Director of Structural & Coronary Intervention, Interventional Cardiology Fellowship Program Director
    HonorHealth, Scottsdale Arizona
    Scottsdale, Arizona, United States

    Disclosure(s): No financial relationships to disclose

  • Suzanne J. Baron, MD, MSc

    Interventional Cardiologist
    Massachusetts General Hospital
    Winchester, Massachusetts, United States

    Disclosure(s): Abiomed Inc: Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Consultant (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consultant (Ongoing); Shockwave Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Bruno Scheller, MD

    Professor of Clinical and Experimental Interventional Cardiology
    University of Saarland
    Homburg, Saarland, Germany

    Disclosure(s): B.Braun: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Sukhdeep S. Bhogal, MD

    Interventional Cardiologist
    Sovah Health
    Roanoke, Virginia, United States

    Disclosure(s): No financial relationships to disclose

  • James B. Hermiller, MD, FACC, MSCAI

    Director Interventional Cardiology
    St. Vincent Medical Group
    Indianapolis, Indiana, United States

    Disclosure(s): Abbott Vascular, Edwards: Consultant (Ongoing)

  • Timir Paul, MD, PhD, FACC, FSCAI

    Professor of Medicine; Program Director, Cardiovascular Disease Fellowship
    University of Tennessee Health Science Center- Nashville, Ascension St. Thomas Hospital
    Brentwood, Tennessee, United States

    Disclosure(s): No financial relationships to disclose

  • Vivian Ng, MD

    Assistant Professor of Medicine
    Columbia University Medical Center
    Douglaston, New York, United States

    Disclosure(s): Boston scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); Medtronic: Consultant (Ongoing); xDOT: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

  • Samin K. Sharma, MD

    Director, Mount Sinai Cardiovascular Clinical Institute
    Mount Sinai Hospital
    New York, New York, United States

    Disclosure information not submitted.

  • AC

    Alaide Chieffo, MD

    Professor of Cardiology
    Vita Salute San Raffaele University - San Raffaele Scientific Institute
    Milan, Lombardia, Italy

    Disclosure information not submitted.